Latest Expert Opinions

Signal
Opinion
Expert
HOLD
HOLD
August 13, 2019
Boycott because of Trump? She owns it, but has taken some profit recently. She would hold on for the next earnings report. They relationship with Trump is not a real issue -- its all about housing. Consumer spending is going up and interest rates are declining, which should help reinvigorate house spending.
Home Depot (HD-N)
August 13, 2019
Boycott because of Trump? She owns it, but has taken some profit recently. She would hold on for the next earnings report. They relationship with Trump is not a real issue -- its all about housing. Consumer spending is going up and interest rates are declining, which should help reinvigorate house spending.
Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$208.330
Owned
Yes
DON'T BUY
DON'T BUY
August 13, 2019
Based out of Markham, they grow by acquisition. She does not own it. They prefer a more balanced organic growth model for the tech space. It is priced fairly highly right now.
Based out of Markham, they grow by acquisition. She does not own it. They prefer a more balanced organic growth model for the tech space. It is priced fairly highly right now.
Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$36.650
Owned
No
COMMENT
COMMENT
August 13, 2019
They have made a lot of positive progress on the balance sheet after the US acquisition. At this point they have done what it is required to stabilize the balance sheet. She does not own it.
Altagas Ltd (ALA-T)
August 13, 2019
They have made a lot of positive progress on the balance sheet after the US acquisition. At this point they have done what it is required to stabilize the balance sheet. She does not own it.
Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$19.750
Owned
No
BUY
BUY
August 13, 2019
She does own this one and the recent pullback offers a good buy in point now. They are generating new synergies and cash flow from the potash and retail operations. The dividend yield is attractive. There was a very delayed planting season in the US, so crop yields will have to be watched going forward. Yield 3.7%
Nutrien Ltd. (NTR-T)
August 13, 2019
She does own this one and the recent pullback offers a good buy in point now. They are generating new synergies and cash flow from the potash and retail operations. The dividend yield is attractive. There was a very delayed planting season in the US, so crop yields will have to be watched going forward. Yield 3.7%
Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$66.440
Owned
Yes
DON'T BUY
DON'T BUY
August 13, 2019

The PFE-N non-patent drugs will be dilutive for earnings in the short term. She prefers either JNJ-N or ABT-N

Pfizer Inc (PFE-N)
August 13, 2019

The PFE-N non-patent drugs will be dilutive for earnings in the short term. She prefers either JNJ-N or ABT-N

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$35.200
Owned
No
DON'T BUY
DON'T BUY
August 13, 2019

The PFE-N non-patent drugs will be dilutive for earnings in the short term. She prefers either JNJ-N or ABT-N

The PFE-N non-patent drugs will be dilutive for earnings in the short term. She prefers either JNJ-N or ABT-N

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$133.420
Owned
No
DON'T BUY
DON'T BUY
August 13, 2019

The PFE-N non-patent drugs will be dilutive for earnings in the short term. She prefers either JNJ-N or ABT-N

Abbott Labs (ABT-N)
August 13, 2019

The PFE-N non-patent drugs will be dilutive for earnings in the short term. She prefers either JNJ-N or ABT-N

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$86.890
Owned
No